SCHEMBL23680290

SCHEMBL23680290

c1ccc2c(c1)oc1ccc(N(c3ccc(C4CCCCC4)cc3)c3ccc(C4CCCCC4)cc3)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
KDM4E B2RXH2 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
LMNA P02545 3/20 0.36
AHR P35869 2/20 0.36
DHODH Q02127 1/20 0.35
CYP2C19 P33261 3/20 0.34
HTT P42858 3/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
CYP2D6 P10635 2/20 0.34
CYP1A2 P05177 1/20 0.34
TP53 P04637 1/20 0.33
CRHBP P24387 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295599 0.96 KMT2A (0.40) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL23691179 0.92 KMT2A (0.42) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL24766770 0.91 KMT2A (0.40) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL25749972 0.91 KMT2A (0.39) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL25749753 0.91 KMT2A (0.39) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL25749980 0.89 KMT2A (0.38) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL25749761 0.89 KMT2A (0.38) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL25749756 0.89 KMT2A (0.38) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL25749976 0.89 KMT2A (0.38) KMT2AMEN1SMN1; SMN2KDM4ENPC1
SCHEMBL27270676 0.88 KMT2A (0.35) KMT2AMEN1SMN1; SMN2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363261-A1 LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-09 US disclosed
US-20230363261-A1 LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-09 US disclosed
US-11744147-B2 Light emitting diode and display device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-29 US disclosed
US-11744147-B2 Light emitting diode and display device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-29 US disclosed
US-20220407028-A1 LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-12-22 US disclosed
US-20210234098-A1 LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-07-29 US disclosed
EP-3855524-A1 LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2021-07-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220407028-A1 LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME ALDH1A2, STRA6, DCX KMT2A 2352/4885MEN1 3856/4885SMN1; SMN2 3290/4885
US-11744147-B2 Light emitting diode and display device including the same ALDH1A2, STRA6, DCX KMT2A 2352/4885MEN1 3856/4885SMN1; SMN2 3290/4885
US-20210234098-A1 LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME ALDH1A2, STRA6, DCX KMT2A 2352/4885MEN1 3856/4885SMN1; SMN2 3290/4885
US-20230363261-A1 LIGHT EMITTING DIODE AND DISPLAY DEVICE INCLUDING THE SAME ALDH1A2, STRA6, DCX KMT2A 2352/4885MEN1 3856/4885SMN1; SMN2 3290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.